A clinical study on CD33-directed chimeric antigen receptormodified NKcells in patient with refractory or relapsed acute myeloid leukemia

被引：1
|
作者：
Xia, Leiming [1 ]
Sun, Xiang [1 ]
Liu, Liu [1 ]
Wang, Yi [1 ]
Li, Tan [1 ]
Li, Bin [1 ]
Wolf, Gregory [2 ]
Li, Qiao [2 ]
Yang, Lin [3 ]
Bao, Yangyi [1 ]
机构：
[1] First Peoples Hosp Hefei, Hefei, Anhui, Peoples R China
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Persongen Biomed, Suzhou, Peoples R China
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
Refractory or relapsed acute myeloid leukemia (R/R AML); CD33; Chimeric antigen receptor (CAR); NK cells; Immunotherapy;
D O I：
10.1158/1538-7445.AM2018-CT060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT060
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark
    Cervantes, Estelle V.
    Ghafoor, Tayyebb
    Reid, Kayla
    Spitler, Kristen
    Yu, Bin
    Betts, Brian C.
    Guevara-Patino, Jose A.
    Maus, Marcela V.
    Davila, Marco L.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [32] Bispecific CD33/CD123 Targeted Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark B.
    Nhan Tu
    Ghafoor, Tayyebb
    Reid, Kayla M.
    Spitler, Kristen
    Yu, Bin
    Maus, Marcela, V
    Davila, Marco L.
    BLOOD, 2022, 140 : 10275 - 10276
  • [33] Clinical Activity and Persistence of Anti-CD22 Chimeric Antigen Receptor in Children and Young Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
    Fry, Terry J.
    Stetler-Stevenson, Maryalice
    Shah, Nirali N.
    Yuan, Constance M.
    Yates, Bonnie
    Delbrook, Cindy
    Zhang, Ling
    Lee, Daniel W., III
    Stroncek, David
    Mackall, Crystal L.
    BLOOD, 2015, 126 (23)
  • [34] Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Azzi, Jacques
    Cooper, Brenda W.
    Deol, Abhinav
    DiPersio, John
    Koura, Divya
    McClune, Brian
    Muffly, Lori S.
    Mushtaq, Muhammad Umair
    Narayan, Rupa
    Suh, Hyung Chan
    Yanik, Gregory
    Nath, Sritama
    Whangbo, Jennifer
    Koehne, Guenther
    BLOOD, 2023, 142
  • [35] Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia
    Shi, Ming
    Li, Li
    Wang, Shiyuan
    Cheng, Hai
    Chen, Wei
    Sang, Wei
    Qi, Kunming
    Li, Zhenyu
    Wang, Gang
    Li, Huizhong
    Lan, Jianping
    Huang, Jinqi
    Fei, Xiaoming
    Yu, Min
    Li, Fei
    Qiao, Jianlin
    Wu, Qingyun
    Zeng, Lingyu
    Jing, Guangjun
    Zheng, Junnian
    Gale, Robert Peter
    Xu, Kailin
    Cao, Jiang
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (06) : 711 - 718
  • [36] Safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+acute myeloid leukemia: A phase Ib study.
    Arain, Saad
    Christian, Sonia
    Patel, Pritesh Rajni
    Sweiss, Karen
    Parkin, Brian
    Calip, Gregory Sampang
    Quigley, John G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia
    Zhang, Hui
    Wang, Pengfei
    Li, Zhuoyan
    He, Yingyi
    Gan, Wenting
    Jiang, Hua
    CLINICAL CANCER RESEARCH, 2021, 27 (13) : 3549 - 3555
  • [38] Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195
    E Feldman
    M Kalaycio
    G Weiner
    S Frankel
    P Schulman
    L Schwartzberg
    J Jurcic
    E Velez-Garcia
    K Seiter
    D Scheinberg
    D Levitt
    N Wedel
    Leukemia, 2003, 17 : 314 - 318
  • [39] CD33 Directed Chimeric Antigen Receptor T Cell Therapy As a Novel Preparative Regimen Prior to Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia
    Kenderian, Saad S.
    Ruella, Marco
    Shestova, Olga
    Klichinsky, Michael
    Scholler, John
    Song, Decheng
    Porter, David L.
    Carroll, Martin
    June, Carl H.
    Gill, Saar
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S25 - S26
  • [40] A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
    Wartman, Lukas D.
    Fiala, Mark A.
    Hawkins, Emily
    Fletcher, Theresa
    Allen, Melissa
    Cashen, Amanda F.
    DiPersio, John F.
    Jacoby, Meagan
    Stockerl-Goldstein, Keith E.
    Pusic, Iskra
    Uy, Geoffrey L.
    Westervelt, Peter
    Vij, Ravi
    BLOOD, 2014, 124 (21)
12345